End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43.8 SEK | -0.23% | +0.92% | +31.14% |
04-22 | EQL Pharma AB Announces Mellozzan Launched in Germany and Austria | CI |
02-13 | EQL Pharma AB Provides Sales Guidance for the Year 2023/24 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+31.14% | 117M | |
-23.27% | 11.73B | |
+12.44% | 6.3B | |
-25.00% | 6.29B | |
-8.91% | 6B | |
-2.48% | 4.63B | |
+60.00% | 4.57B | |
-6.67% | 3.89B | |
-10.84% | 3.5B | |
-6.06% | 3.04B |
- Stock Market
- Equities
- EQL Stock
- News EQL Pharma AB
- Sweden's EQL Pharma Signs License Agreement for Melatonin Product in Turkey, Kazakhstan